Patricia M. McGowan

The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?

Michael J. Duffy, Maeve Mullooly, Norma O’Donovan et al. · Clinical Proteomics · 2011 · 200 citations · Full text

Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database

Patricia M. McGowan, Michael J. Duffy · Annals of Oncology · 2008 · 163 citations · Full text

Breast Oncology, Medicine, Matrix Metalloproteinase Expression +9

Neratinib overcomes trastuzumab resistance in HER2 amplified breast cancer

Alexandra Canonici, Merel Gijsen, Maeve Mullooly et al. · Oncotarget · 2013 · 162 citations · Full text

Trastuzumab Resistance, Breast Oncology, Trastuzumab-sensitive Breast Cancer +13

Notch1 Inhibition Alters the CD44hi/CD24lo Population and Reduces the Formation of Brain Metastases from Breast Cancer

Patricia M. McGowan, Carmen Simedrea, Emeline J. Ribot et al. · Molecular Cancer Research · 2011 · 145 citations · Full text

Stem Cell Biology, Cd44hi/cd24lo Population, Medicine +15

Trastuzumab induces antibody-dependent cell-mediated cytotoxicity (ADCC) in HER-2-non-amplified breast cancer cell lines

Denis M. Collins, Norma O’Donovan, Patricia M. McGowan et al. · Annals of Oncology · 2011 · 140 citations · Full text